Verseon Corporation Additional Listing & Total Voting Rights (6129A)

TIDMVSN

RNS Number : 6129A

Verseon Corporation

02 January 2018

January 2, 2018

Verseon Corporation

("Verseon" or the "Company")

Additional Listing & Total Voting Rights

Fremont, Calif.-Verseon, a technology-based pharmaceutical company, announces that application has been made for 24,096 new shares of common stock ("Common Shares") of par value $0.001 each to be admitted to trading on AIM pursuant to regularly scheduled vesting of restricted stock units (the "Issuance"). The restricted stock units ("RSU") have been issued to Dr. Thomas Hecht and Dr. Robert Karr, both non-executive Directors of the Company, in relation to the payment of their Director's fees. Of the 24,096 Common Shares issued, 18,072 Common Shares were issued to Dr. Hecht and 6,024 to Dr. Karr.

Each Director received a stock grant of 36,144 Common Shares for one year of service, as calculated by reference to the closing price of USD 1.66 of the Company's Common Shares on October 19, 2017. For Dr. Hecht, 18,072 Common Shares have vested on December 31, 2017 and 25% will vest each quarter thereafter, ending on June 30, 2018. For Dr. Karr, 6,024 Common Shares have vested on December 31, 2017 and 25% will vest each quarter thereafter, ending on October 31, 2018.

Following the Issuance, Dr. Hecht will hold 63,400 Common Shares, representing 0.04% of the Company's issued share capital. Dr. Karr will hold 191,288 Common Shares, representing 0.13% of the Company's issued share capital.

The 24,096 new Common Shares issued pursuant to the Issuance will rank pari passu with the Company's existing Common Shares and admission to trading on AIM is expected to take place on January 5, 2018 ("Admission").

Total Voting Rights

Following Admission, the issued share capital of the Company will consist of 151,556,802 Common Shares and the Company will hold 42,917 shares in treasury. Therefore, the total number of Common Shares in the Company with voting rights will be 151,513,885. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact:

 
 Verseon Corporation                www.verseon.com 
                                    +1 (510) 225 
 Tina Schlafly                       9000 
 
 Cenkos Securities (NOMAD and 
  Joint Broker) 
                                     +44 (0) 20 
 Neil McDonald / Beth McKiernan       7397 8900 
 
 Cantor Fitzgerald Europe (Joint 
  Broker) 
 Marc Milmo / Phil Davies /         +44 (0) 20 
  Callum Butterfield                 7894 7000 
 
 

For financial and business media enquiries, please contact

 
 Buchanan Communications Ltd 
  (PR Advisers) 
 Henry Harrison-Topham / Jamie    +44 (0) 20 
  Hooper                           7466 5000 
 

For trade and pharma media enquiries, please contact

 
 Vane Percy & Roberts 
                         +44 (0) 1737 
 Simon Vane Percy         821 890 
 
 
 1     Details of the person discharging managerial 
        responsibilities / person closely associated 
----  -------------------------------------------------------- 
 a)    Name                        Dr. Thomas Hecht 
----  --------------------------  ---------------------------- 
 2     Reason for the notification 
----  -------------------------------------------------------- 
 a)    Position/status             Non-Executive Chairman 
----  --------------------------  ---------------------------- 
 b)    Initial notification        Initial notification 
        /Amendment 
----  --------------------------  ---------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  -------------------------------------------------------- 
 a)    Name                        Verseon Corporation 
----  --------------------------  ---------------------------- 
 b)    LEI                         N/a 
----  --------------------------  ---------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  -------------------------------------------------------- 
 a)    Description of              Restricted stock grant of 
        the financial               Common Shares of par value 
        instrument, type            $0.001 
        of instrument 
 
        Identification              ISIN: USU9221J1098 
        code 
----  --------------------------  ---------------------------- 
 b)    Nature of the               Vesting of restricted stock 
        transaction                 units 
----  --------------------------  ---------------------------- 
 c)    Price(s) and volume(s)        Price(s)    Volume(s) 
                                     ----------  ---------- 
                                      -           18,072 
                                     ----------  ---------- 
----  --------------------------  ---------------------------- 
       Aggregated information 
 
        - Aggregated volume          18,072 
 
 
 d)     - Price                      - 
----  --------------------------  ---------------------------- 
 e)    Date of the transaction     31 December 2017 
----  --------------------------  ---------------------------- 
 f)    Place of the transaction    N/a 
----  --------------------------  ---------------------------- 
 
 
 1     Details of the person discharging managerial 
        responsibilities / person closely associated 
----  -------------------------------------------------------- 
 a)    Name                        Dr. Robert Karr 
----  --------------------------  ---------------------------- 
 2     Reason for the notification 
----  -------------------------------------------------------- 
 a)    Position/status             Non-Executive Chairman 
----  --------------------------  ---------------------------- 
 b)    Initial notification        Initial notification 
        /Amendment 
----  --------------------------  ---------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  -------------------------------------------------------- 
 a)    Name                        Verseon Corporation 
----  --------------------------  ---------------------------- 
 b)    LEI                         N/a 
----  --------------------------  ---------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  -------------------------------------------------------- 
 a)    Description of              Restricted stock grant of 
        the financial               Common Shares of par value 
        instrument, type            $0.001 
        of instrument 
 
        Identification              ISIN: USU9221J1098 
        code 
----  --------------------------  ---------------------------- 
 b)    Nature of the               Vesting of restricted stock 
        transaction                 units 
----  --------------------------  ---------------------------- 
 c)    Price(s) and volume(s)        Price(s)    Volume(s) 
                                     ----------  ---------- 
                                      -           6,024 
                                     ----------  ---------- 
----  --------------------------  ---------------------------- 
       Aggregated information 
 
        - Aggregated volume          6,024 
 
 
 d)     - Price                      - 
----  --------------------------  ---------------------------- 
 e)    Date of the transaction     31 December 2017 
----  --------------------------  ---------------------------- 
 f)    Place of the transaction    N/a 
----  --------------------------  ---------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEAAANADAXFFF

(END) Dow Jones Newswires

January 02, 2018 02:00 ET (07:00 GMT)